Siegfried Holding AG (0QQO.L) LSE

79.07

-0.21822(-0.28%)

Updated at June 02 06:28PM

Currency In CHF

Siegfried Holding AG

Address

Untere Bruehlstrasse 4

Zofingen, 4800

Switzerland

Phone

41 62 746 1111

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

3886

First IPO Date

October 13, 2014

Key Executives

NameTitlePayYear Born
Marcel ImwinkelriedChief Executive Officer & Chief Operating Officer Drug Products ad interim1.66M1967
Beatrice HarderHead Regulatory Affairs - Site Zofingen0N/A
Olesia SilantevaChief Human Resources Officer01982
Stefan RandlInterim Chief Operating Officer Drug Substances & Chief Scientific Officer0N/A
Luca Dalla TorreChief Legal & Sustainability Officer0N/A
Reto SuterChief Financial Officer01971
Florent TrouilletHead Corporate Quality Systems - Global Quality Systems0N/A
Peter StierliHead of Corporate Communications0N/A
John JonesHead of Operations - Malta0N/A
Enno SchweinbergerHead Global Quality Management DS - Zofingen0N/A

Description

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.